Author:
Verma Jyoti,Lal Sumit,Van Noorden Cornelis J.F.
Abstract
AbstractTheranostics are a multifunctional approach using nanoparticles for combined diagnostic and therapeutic purposes. The hybrid nanoparticles that are applied for these purposes are composed of an inorganic core and an organic shell. The inorganic core acts as a contrast enhancer and the organic shell acts as a drug releaser. Hybrid nanoparticles can be conjugated with targeting moieties and systematically administered to patients to direct the nanoparticles to specific cells such as cancer cells. Theranostics have the potential to significantly improve early stage cancer diagnostics and patient survival. This review discusses preclinical and clinical advances in applications of inorganic nanoparticles for the theranostics of cancer.
Subject
Physical and Theoretical Chemistry,Biomedical Engineering,Medicine (miscellaneous),Bioengineering
Reference252 articles.
1. Detection of circulating tumor cells in human peripheral blood using surface - enhanced raman scattering nanoparticles;Wang;Cancer Res,2011
2. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging;Veiseh;Adv Drug Deliv Rev,2010
3. Inorganic nanoparticles for cancer imaging and therapy;Huang;J Control Release,2011
4. Surface - modified silica nanoparticles for tumor - targeted delivery of camptothecin and its biological evaluation Control;Botella,2011
5. In vivo mri detection of gliomas by chlorotoxin - conjugated superparamagnetic nanoprobes;Sun;Small,2008
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献